Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05841615
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2023-04-04
Brief Title:
Pulmonary Vein Isolation PVI Combined With Renal Denervation RDN in Atrial Fibrillation AF and Hypertension HTN
Sponsor:
The First Affiliated Hospital of Xiamen University
Organization:
The First Affiliated Hospital of Xiamen University
Study Overview
Official Title:
Evaluation of the Safety and Efficacy of Pulmonary Vein Isolation PVI Combined With Renal Denervation RDN in Patients With Atrial Fibrillation AF and Hypertension HTN
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The close relationship between the increase of sympathetic tension AF and HTN cannot be ignored In addition the significant failure rate of PVI 20-50 in the treatment of AF makes it very necessary to explore the effect of RDN on AF Therefore this study aims to compare the effects and safety of PVI alone and PVI combined with RDN with AF combined with HTN which will open a new chapter for PVI combined with RDN in the treatment of AF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None